AFT Forsyth & Company Inc. Lowers Position in The Clorox Company (NYSE:CLX)

AFT Forsyth & Company Inc. trimmed its holdings in shares of The Clorox Company (NYSE:CLX) by 5.1% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 1,880 shares of the company’s stock after selling 100 shares during the period. AFT Forsyth & Company Inc.’s holdings in Clorox were worth $305,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of CLX. Mizuho Securities USA LLC lifted its position in Clorox by 46,877.8% during the third quarter. Mizuho Securities USA LLC now owns 4,500,000 shares of the company’s stock valued at $733,095,000 after buying an additional 4,490,421 shares in the last quarter. Ilex Capital Partners UK LLP lifted its position in Clorox by 512.7% during the third quarter. Ilex Capital Partners UK LLP now owns 542,110 shares of the company’s stock valued at $88,315,000 after buying an additional 453,624 shares in the last quarter. International Assets Investment Management LLC lifted its position in Clorox by 424.9% during the third quarter. International Assets Investment Management LLC now owns 538,576 shares of the company’s stock valued at $877,390,000 after buying an additional 435,971 shares in the last quarter. Boston Trust Walden Corp lifted its position in Clorox by 5,442.5% during the third quarter. Boston Trust Walden Corp now owns 273,908 shares of the company’s stock valued at $44,622,000 after buying an additional 268,966 shares in the last quarter. Finally, Assenagon Asset Management S.A. lifted its position in Clorox by 302.0% during the fourth quarter. Assenagon Asset Management S.A. now owns 353,367 shares of the company’s stock valued at $57,390,000 after buying an additional 265,455 shares in the last quarter. 78.53% of the stock is owned by institutional investors and hedge funds.

Clorox Trading Up 0.2 %

CLX opened at $148.66 on Thursday. The company has a debt-to-equity ratio of 20.52, a current ratio of 0.94 and a quick ratio of 0.62. The Clorox Company has a 12-month low of $127.60 and a 12-month high of $171.37. The firm’s fifty day moving average price is $160.30 and its 200 day moving average price is $159.26. The stock has a market capitalization of $18.40 billion, a PE ratio of 40.62, a P/E/G ratio of 2.52 and a beta of 0.42.

Clorox (NYSE:CLX) last released its earnings results on Monday, February 3rd. The company reported $1.55 earnings per share for the quarter, beating the consensus estimate of $1.39 by $0.16. Clorox had a net margin of 6.38% and a return on equity of 316.87%. During the same quarter last year, the business earned $2.16 earnings per share. As a group, research analysts expect that The Clorox Company will post 7.15 EPS for the current fiscal year.

Clorox Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, February 14th. Shareholders of record on Wednesday, January 29th will be paid a dividend of $1.22 per share. The ex-dividend date is Wednesday, January 29th. This represents a $4.88 annualized dividend and a yield of 3.28%. Clorox’s payout ratio is 133.33%.

Wall Street Analysts Forecast Growth

A number of research firms have recently commented on CLX. Barclays boosted their target price on shares of Clorox from $130.00 to $140.00 and gave the stock an “underweight” rating in a research report on Wednesday, February 5th. Royal Bank of Canada reissued a “sector perform” rating and set a $150.00 target price on shares of Clorox in a research report on Thursday, January 30th. Evercore ISI boosted their target price on shares of Clorox from $145.00 to $155.00 in a research report on Tuesday, February 4th. TD Cowen raised shares of Clorox from a “sell” rating to a “hold” rating and boosted their target price for the stock from $155.00 to $170.00 in a research report on Wednesday, November 6th. Finally, DA Davidson reduced their target price on shares of Clorox from $171.00 to $169.00 and set a “neutral” rating on the stock in a research report on Wednesday, February 5th. Four investment analysts have rated the stock with a sell rating, eleven have issued a hold rating and one has assigned a buy rating to the stock. According to MarketBeat, Clorox presently has an average rating of “Hold” and a consensus price target of $158.21.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.